Portopulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Portopulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-12-07Clinical Trial Update: Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension [Phase 4]
Phase 4 trial evaluating ambrisentan plus tadalafil for portopulmonary hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-17Clinical Trial Update: Ambrisentan for Treatment of Portopulmonary Hypertension [Phase 1, Phase 2]
The Phase 1/2 trial of Ambrisentan for portopulmonary hypertension has been withdrawn.